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ABSTRACT. Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation
and management of chronic inflammatory arthritis. We summarize here results of the Outcome
Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These
results were reported at the OMERACT 12 meeting at the plenary session and discussed during
breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade
and its contribution to understanding musculoskeletal diseases. This is the first update report of WG
activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative
diseases, including pediatric arthritis, since the OMERACT 11 meeting. (First Release March 15
2015; J Rheumatol 2015;42:2172–6; doi:10.3899/jrheum.141462)
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As of 2015, musculoskeletal ultrasound (US) can no longer
be considered as controversial in rheumatology; on the
contrary, US thrives as an established imaging modality for
the investigation and management of chronic inflammatory
arthritis. Last year marked the 10-year jubilee of the
OMERACT US working group (WG). Members of the WG
met in Budapest, Hungary, for the OMERACT 12
conference, where results of the last 2 years of ongoing
projects were presented. The several milestones reached in
standardizing the use of US in rheumatic disease over the
last decade and the contribution of US to understanding
musculoskeletal diseases were highlighted in the plenary
session and discussed during breakout sessions. This report
provides an update on the activities of the WG in validating
US as an outcome measure in musculoskeletal inflam-
matory and degenerative diseases including pediatric
arthritis, since the last report on WG activities at
OMERACT 111. 
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A Decade Put into Historical Perspective 
At OMERACT 7 in 2004, a special interest group (SIG)
dedicated to US was formed by a group of international
rheumatologists with the aim of exploring the metric
properties of musculoskeletal US. At this early stage, a
systematic review of the musculoskeletal US literature in
rheumatoid arthritis (RA)2 dissected the various gaps in
existing knowledge, particularly underscoring the lack of US
definitions of rheumatic pathology, instrument reliability, and
instrument validity. Overall agreement was that because
research resources of the SIG were limited, efforts had to be
strictly prioritized. The very first publication of the group
reported on a core set of practical US definitions for general
rheumatic manifestations including synovitis, tenosynovitis,
and erosions3. In considering which strategy to use, iterative
exercises on synovitis in patients with RA were carried out
from 2004 to 2010. These exercises involved US assessment
of synovitis at both the patient level and the joint level4,5,6,7.
It was not surprising that the intra- and interexaminer κ
values for reading still images were better than for those of
real-time image acquisition8. 
By 2008, the perspective of developing an US disease
activity score based on synovitis at the patient level loomed
as a logical next step, i.e., a global synovitis score (GLOSS).
Development of a GLOSS was the result of an iterative,
gradual, slow-moving process, implicating a step-by-step
approach that included several issues, e.g., the optimal
number of joints, how to scan these (dorsal, volar), and
B-mode alone or in combination with power Doppler. On the
basis of favorable results of the preceding exercises4,5,6,7, an
US-GLOSS, combining B-mode synovial hypertrophy and
power Doppler in 1 score, was presented at OMERACT 108.
An additional advantage is that the GLOSS can be performed
à la carte, i.e., in various joint number configurations.
Subsequently, responsiveness of the GLOSS was tested in an
international multicenter open-label medication trial evalu-
ating responsiveness of power Doppler US in patients with
RA with incomplete clinical response to methotrexate and
treated with abatacept9. Preliminary results were reported at
OMERACT 1110. During the group discussions and feedback
sessions, a need for separate development of diagnostic and
monitoring RA GLOSS systems was expressed. Currently,
questions need to be addressed on which US findings are
preferred for establishing a definite diagnosis (i.e., discrimi-
nation findings), and which findings are preferred for
monitoring purposes, or for predicting/evaluating remission
or flare for that matter. In addition, it is not yet clear how
frequently US scans have to be repeated11. Two ongoing trials
are assessing some of these aspects, namely, the TURA study
(NTC 02056184), which is a longitudinal international
randomized controlled trial (RCT) targeting remission, and
the REVECHO study (NCT02140229), which is a longitu-
dinal international RCT targeting the best strategy for
maintaining longstanding remission.
As mentioned in the preceding report of OMERACT 11,
testing the metric properties of US on tenosynovitis and
tendon damage in patients with RA was another prioritized
research area12,13,14,15. From a clinical point of view, tendon
damage may be an important endpoint in RCT; it would also
be clinically relevant to understand which US findings at joint
and tendon level are able to predict tendon damage. Results
of the tendon damage study in patients with RA showed good
to excellent κ values for intraobserver and interobserver relia-
bility14. Additionally, an atlas of US images on tenosynovitis
and tendon damage in RA was published as online material15. 
Current Research Agenda. “True Erosion,” Gout,
Pediatric Arthritis, OA, and Dactylitis
During the workshop, the ongoing research agenda focused
on additional data including the validation of US in RA
erosions and in pediatric arthritis, as well as on new devel-
opment of US as an outcome measure for other inflammatory
rheumatic diseases, such as psoriatic arthritis (PsA) and gout.
These topics were first presented in the plenary introduction
and then discussed in the breakout sessions. 
The first topic focused on the validation of US for
detecting RA bone erosions. S. Finzel presented new findings
on the prevalence of erosions versus normal cortical “breaks”
in patients with RA and healthy controls, using
high-resolution peripheral quantitative computed tomography
as the gold standard. The rationale of these studies is to get a
better idea of what a “true US erosion” represents. Sub-
sequently, the intraobserver and interobserver reliability of
US detecting these structures was tested in patients with RA
and healthy controls by 12 rheumatologists expert in US
(Table 1). Based on the outcome of this study, further studies
are planned to define an US-detected RA erosion and the
minimal size that can be accurately detected. 
Next, a presentation by L. Terslev provided insights into
how US can assess the 3 key domains in gout, i.e., inflam-
mation, damage, and urate load16. By using a previous
systematic literature review, 4 elementary US components
were identified, i.e., double contour sign, aggregates, tophi,
and erosion17. The US definitions of these 4 identified lesions
were agreed upon by the group using a Delphi exercise18.
Subsequently, the metric properties of these components were
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Table 1. US testing intraobserver and interobserver reliability on small
erosions in patients with RA and healthy controls.
Intraobserver Interobserver
Normal Abnormal Normal Abnormal 
Break Break Break Break
Palmar long 0.1–0.8 0.6–0.9 0.8 0.9
Dorsal long 0.4–0.6 –0.1–0.5 0.4 0.7
Palmar transv 0.2–0.7 0.5–0.7 0.7 0.5
Dorsal transv 0.3–0.9 0.4–0.8 0.3 0.4
US: ultrasound; RA: rheumatoid arthritis. 
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assessed in a patient reliability study conducted in Berlin,
December 2013. Preliminary results were presented, showing
acceptable intraobserver reliability for detecting and
acquiring images of double contour, tophi, and erosions, but
not for aggregates. Interobserver κ values were even lower16.
On the basis of the reliability results, overall agreement was
that further validation was needed for double contour sign
and aggregates.
A. Iagnocco presented work conducted in hand osteo-
arthritis (OA). Results of a reliability study focusing on
cartilage damage showed intrarater and interrater κ of 0.52
and 0.80 using dichotomous scoring19. A second reliability
exercise was aimed at evaluating the possibility to grade
together structural damage in hand OA, by using a semiquan-
titative grading of both cartilage and osteophyte lesions. This
study showed good results for osteophyte scoring, but
moderate for cartilage20. Overall agreement was that an US
core domain set to be used in hand OA structural lesions
should include cartilage scoring in a dichotomous way and
osteophyte scoring on a semiquantitative scale (0–3).
J. Roth presented the latest concepts of how US can be
used as an instrument for assessment of pediatric pathology.
A core domain set for pediatric pathology has yet to be deter-
mined. The US definitions of joints of healthy children have
recently been published21. The next step is to define synovitis
in children with juvenile idiopathic arthritis (JIA), which shall
be done by consensus through consecutive Delphi rounds.
The main objective of the pediatric Delphi process is to
obtain consensus on the B-mode and Doppler US elementary
components to include in the definition of synovitis in
children. The secondary objective is to obtain consensus on
the type of scoring system that will be developed. Both the
synovitis definition and the scoring system will subsequently
be tested in future US exercises in children with JIA. 
The last topic was dactylitis, presented by G. Kaeley. He
explained that dactylitis was identified as part of a domain
core set for PsA. US candidate elementary components have
been identified through a literature review22. A Delphi
process is under way to reach consensus on the initial set of
elements that warrant study. Based on the results of the first
round, the candidate elements were prioritized (Figure 1). A
second round of the Delphi process is being conducted to
plan a reliability exercise looking at evaluating the identified
elementary lesions. 
Following these presentations, each subgroup was divided
into smaller discussion groups (about 15 participants each,
including 2 patient partners), who were then asked to
consider a set of 4 draft questions based on endorsement of
the work done and the future research agenda of the group
by OMERACT participants (Table 2). Draft questions
pertained to construct validity of hand OA, a core domain set
of US to be used in gout patients, a core domain set to be used
in patients with PsA, and lastly, future research in RA
erosions. Each discussion group then reported its main points
to all participants at the end of the breakout sessions. 
Following this report, the questions were voted on for
2174 The Journal of Rheumatology 2015; 42:11; doi:10.3899/jrheum.141462
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Figure 1. Categorization of candidate elements in dactylitis into domains after first round of
Delphi process. Nail plate Tri Loss / Irrg: loss of nail plate trilaminar structure and/or irregu-
larity of nail plate; Intracap calcification: intracapsular calcification; Lig: ligament; Tend.:
tendon; Enth.: enthesitis. 
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potential endorsement by all conference participants at the
final plenary session on the last day of the conference. The
topics proposed in the formulated questions were endorsed
by a strong majority of attendees. 
Below, the main points of discussion are reported.
Regarding the US detection of erosions, there was
wide-spread recognition of the importance of developing an
US validated measure of erosions, since this tool is widely
introduced in the evaluation of RA synovitis. Participants
agreed that the evaluation of erosions by US would provide
valuable support for early detection of erosive disease. In
addition, the higher sensitivity of US for detecting erosions
compared to radiography, owing to its better resolution and
to the tomographic nature of the technique, is considered an
added value. The detection of erosions in early inflammatory
disease was felt to be a priority research area and an objective
to be tested in future clinical trials. However, additional
validation was required before proposing US as a standard
outcome measurement of structural damage. For example,
more data on the discriminative capability of US for distin-
guishing between normal cortical breaks and small erosions
is needed. One breakout group pointed out the need for
additional RCT supporting the responsiveness of inflam-
matory findings, such as synovitis, before moving to struc-
tural damage. Nevertheless, general agreement was expressed
on the potential interest of this tool in evaluating erosions. 
There was also strong agreement that US is a valuable tool
for evaluation of patients with gout. Based on discussions in
the breakout groups, several key points were raised by partici-
pants, especially as related to the role of US in gout. The
importance of US in evaluating urate load was underscored.
Participants agreed on the valuable role of US in distin-
guishing and measuring acute and chronic gout and in identi-
fying core domains for both stages of disease (tophi, synovial
inflammation, aggregates, and urate deposits). However,
there remains a lack of clear definitions of elementary lesions
detected by US. Therefore, discussions were mostly related
to which lesions should be assessed by US and which defini-
tions should be used. The discriminative ability of US gout
lesions in comparison to other arthropathies has been
suggested as a priority for validation. 
The third question, based on the development of US in
PsA, also received agreement from the majority of partici-
pants. In each breakout group in which this topic was
discussed, unanimous concordance on the need to pursue
standardization of US for management of PsA was reached.
The value of US in the evaluation of PSA synovitis was
recognized and supported, as well as the potential value of
US in the evaluation of dactylitis. The development of US as
a responsive tool for following this clinical manifestation was
unanimously supported. Finally, the potential development
of a structural US score in hand OA was discussed. On the
basis of the work already performed by the WG in terms of
inflammatory abnormalities, agreement was obtained that the
future research agenda should focus on correlations between
structural and inflammatory lesions and clinical outcomes in
symptomatic hand OA.
The objectives of this workshop were to present both the
existing knowledge on the use of US in areas that have been
explored over the last decade and to decide priorities for
future research. US is a unique outcome measure that reveals
both the past and present status of various rheumatic diseases.
Considerable progress has been reported in different areas,
including synovitis and structural damage in RA, tenosyn-
ovitis in RA, and structural damage in hand OA. At this stage
it is not possible to predict the influence of the workshop’s
success in these areas, but the effects may be far-reaching,
both for daily practice and clinical research. Examples of the
aspect of daily practice may be other treatment expectations
or less use of radiographic radiation; an example of the
clinical research aspect may be novel insights into patho-
genetic mechanisms, e.g., in OA. 
Here follows the research agenda drafted to address
existing gaps in our knowledge regarding work to be done in
hand OA, gout, PsA, and erosions (Table 3):
• To investigate the construct validity of US assessment of
hand OA as compared to clinical manifestations of the
disease
• To assess the metric properties of US in other OA joints
(e.g., the knee)
• To further define the basic abnormalities evaluable with
US in gout and to test the reliability, responsiveness, and
discriminant capacity of these lesions
• To further identify and define the basic US abnormalities
that can be included in the US assessment of PsA and to
test their metric properties
• To further address the concurrent validity and sensitivity
to change of US-detected early bone erosions
• To develop definitions for joint inflammatory pathology
in childhood
Other areas of future research include systemic vasculitis,
synovial biopsy, and knee OA. Over the next 2 years, fresh
data will be reported on the different topics of the research
agenda. 
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Table 2. Endorsement of 4 voting questions in the final plenary session.
Voting Question Endorsement, %
Do you agree to investigate the correlation between 
structural damage and inflammation and clinical 
outcomes in hand OA? 81
Do you agree that US can be developed as an 
outcome instrument in dactylitis? 77
Do you agree that an ultrasound domain core set in gout 
should include urate load, inflammation, and damage? 76
Following successful work on synovitis and tenosynovitis 
in RA, should we continue to work on erosions? 76
OA: osteoarthritis; US: ultrasound; RA: rheumatoid arthritis.
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APPENDIX
List of study collaborators: OMERACT Ultrasound Task Force: Philippe
Aegerter, Sibel Aydin, Marina Backhaus, David Bong, Isabelle
Chary-Valckenaere, Paz Collado, Eugenio De Miguel, Christian Dejaco,
Oscar Epis, Jane E. Freeston, Frederique Gandjbakhch, Walter Grassi, Petra
Hanova, Sandrine Jousse-Joulin, Fredrick Joshua, Juhani Koski, Damien
Loeuille, Ingrid Möller, Viviana Ravagnani, Anthony Reginato, Veronica
Sharp, Nanno Swen, Marcin Szkudlarek, Richard J. Wakefield, and 
Hans-Rudolf Ziswiler. 
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Table 3. Future research agenda and time line of the OMERACT US working
group.
US Research Field Outcome Research Phase
Detection of minimal Minimal erosion Validity studies
erosions in RA
Definition of an US Inflammation, damage, Delphi study on 
core domain set in urate load definitions/reliability
gout
Definition of an US Structural lesions Delphi study/reliability
core domain set in hand 
OA
Definition of an US core Dactylitis Delphi study
domain set in PsA
Definition of an US Synovitis Delphi study on
core domain set in normal sonoanatomy
pediatric arthritis and synovitis
US: ultrasonography; RA: rheumatoid arthritis; OA: osteoarthritis; PsA:
psoriatic arthritis.
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